Prenetics Global (PRE) Stock Overview
A consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
PRE Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Prenetics Global Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.60 |
| 52 Week High | US$11.99 |
| 52 Week Low | US$3.09 |
| Beta | 0.15 |
| 1 Month Change | -3.92% |
| 3 Month Change | 9.67% |
| 1 Year Change | 38.69% |
| 3 Year Change | -87.04% |
| 5 Year Change | n/a |
| Change since IPO | -93.48% |
Recent News & Updates
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 50% Share Price Bounce
May 11
What You Can Learn From Prenetics Global Limited's (NASDAQ:PRE) P/S After Its 27% Share Price Crash
Mar 27Recent updates
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 50% Share Price Bounce
May 11What You Can Learn From Prenetics Global Limited's (NASDAQ:PRE) P/S After Its 27% Share Price Crash
Mar 27Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce
Dec 16Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors
Oct 12Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump
May 29Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues
Apr 08Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%
Jan 07Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M
Sep 09Shareholder Returns
| PRE | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 2.4% | 9.6% | 1.0% |
| 1Y | 38.7% | -28.5% | 17.0% |
Return vs Industry: PRE exceeded the US Healthcare industry which returned -28.5% over the past year.
Return vs Market: PRE exceeded the US Market which returned 17% over the past year.
Price Volatility
| PRE volatility | |
|---|---|
| PRE Average Weekly Movement | 18.5% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PRE's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PRE's weekly volatility has increased from 13% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 285 | Danny Yeung | www.prenetics.com |
Prenetics Global Limited, a consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally. The company operates in three segments: Prevention, Diagnostics, and Consumer Health. It operates IM8 Health that sells health and wellness products; and provides fulfillment and distribution services for sports nutrition products under the Consumer Health segment.
Prenetics Global Limited Fundamentals Summary
| PRE fundamental statistics | |
|---|---|
| Market cap | US$99.06m |
| Earnings (TTM) | -US$48.17m |
| Revenue (TTM) | US$41.52m |
Is PRE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRE income statement (TTM) | |
|---|---|
| Revenue | US$41.52m |
| Cost of Revenue | US$22.56m |
| Gross Profit | US$18.96m |
| Other Expenses | US$67.13m |
| Earnings | -US$48.17m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.70 |
| Gross Margin | 45.66% |
| Net Profit Margin | -116.01% |
| Debt/Equity Ratio | 0% |
How did PRE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/17 12:17 |
| End of Day Share Price | 2025/08/15 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Prenetics Global Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ross Osborn | Cantor Fitzgerald & Co. |